RYAM in the news

RYAM targets positive cash flow and specialty leadership by 2026 with new products and disciplined execution.

Rayonier Advanced Materials presented a slide deck at the Gabelli Funds Specialty Chemicals Symposium in March 2026.

Rayonier Advanced Materials is executing a strategic turnaround focusing on cash flow positivity, EBITDA growth, asset utilization, and debt refinancing by 2027 amidst market and financial challenges.

Rayonier Advanced Materials saw reduced short interest and increased institutional investment, reported a quarterly loss but beat revenue estimates, and holds a Hold rating with a $14 target price.

Rayonier Advanced Materials stock reached a 52-week high amid mixed analyst ratings and recent institutional buying, despite a quarterly loss.

RYAM CEO Scott Sutton will present at a major chemicals symposium, highlighting the company's leadership in cellulose-based products and its global operations.

RYAM CEO Scott Sutton will present at a specialty chemicals symposium highlighting the company's leadership in cellulose products used across multiple industries and their global manufacturing footprint.

RYAM CEO Scott Sutton will present at the 2026 Gabelli Specialty Chemicals Symposium, highlighting the company's leadership in cellulose-based products and its global operations.

RYAM's new CEO focuses on improving cash flow and operational momentum by 2026 amid ongoing losses and rejected buyout offers.

Rayonier Advanced Materials plans to improve 2026 cash flow and EBITDA by raising cellulose specialties prices, optimizing production, launching new products, and managing debt.

American Century Companies and other institutional investors increased their stakes in Rayonier Advanced Materials, a cellulose and engineered wood products company, amid mixed analyst ratings and recent earnings results.

Rayonier Advanced Materials stock hit a new high amid mixed analyst ratings and strong institutional buying, despite recent quarterly losses.

Rayonier Advanced Materials SVP Ribeyrolle received 4,113 shares from a performance-based stock award vesting over three years.

Rayonier Advanced Materials reported a larger-than-expected Q4 loss but beat revenue estimates, with stock gains year-to-date and a hold rating due to mixed earnings outlook.

Rayonier Advanced Materials posted heavy losses in FY 2025 with a $423 million net loss and ongoing operational challenges, raising concerns about its path to profitability despite steady revenue.

Rayonier Advanced Materials declined a private equity acquisition offer that proposed merging it with another cellulose products maker, but interest from a New York investor remains.

Rayonier Advanced Materials' stock price targets have been raised due to strategic repricing and value-focused efforts, alongside a planned CEO transition in 2026.

RYAM reported a challenging 2025 with losses but plans focused on cash flow improvement and disciplined execution in 2026 to strengthen its cellulose specialties business.

Analysts show mixed but generally positive ratings for Rayonier Advanced Materials, MP Materials, and Albemarle with varying price targets.

A private equity firm offered to buy struggling Rayonier Advanced Materials at twice its stock price, but the board rejected the bid despite potential industry consolidation.